Skip to main content
Top
Published in: International Journal of Hematology 4/2018

01-10-2018 | Original Article

Molecular characterization of Hb H disease in southern Thailand

Authors: Kesara Nittayaboon, Chamnong Nopparatana

Published in: International Journal of Hematology | Issue 4/2018

Login to get access

Abstract

Genotypes of 260 individuals with hemoglobin H (Hb H) disease originating from various provinces in southern Thailand were characterized by multiplex PCR (M-PCR) and reverse dot blot hybridization (RDB). M-PCR was used to amplify target fragments and then hybridized with allele-specific oligonucleotide (ASO) probes which were bound on a nylon membrane. A total of eight α-thalassemia (α-thal) mutations, which produced eight Hb H disease genotypes (α0-thal/α+-thal), were detected. The most common form of α0-thal was −SEA with a frequency of 99.23%. The other form (0.77%) of α0-thal mutation was a THAI deletion (−THAI). The deletional α+-thal mutations comprised 3.7 kb (-α3.7) and 4.2 kb (-α4.2) deletions which were found in 172 (66.15%) and 5 (1.92%) alleles, respectively. The incidence of non-deletional α+-thal in decreasing order was Hb Constant Spring (Hb CS, αCS) 28.85%, Hb Quong Sze (Hb QS, αQS) 1.54%, and Hb Paksé (Hb PS, αPS) 0.77%. The genotype characterization of Hb H disease and the development of the RDB technic for detection of α-thal mutations presented in this study enable the prenatal diagnosis of Hb Bart’s hydrops fetalis syndrome.
Literature
2.
go back to reference Chui DHK. Thalassemia. Hb H disease and Hb Bart’s hydrops fetalis. Ann N Y Acad Sci. 2005;1054:25–32.CrossRefPubMed Chui DHK. Thalassemia. Hb H disease and Hb Bart’s hydrops fetalis. Ann N Y Acad Sci. 2005;1054:25–32.CrossRefPubMed
3.
go back to reference Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong province: implications for the future health burden and population screening. J Clin Pathol. 2004;57:517–22.CrossRefPubMedPubMedCentral Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong province: implications for the future health burden and population screening. J Clin Pathol. 2004;57:517–22.CrossRefPubMedPubMedCentral
5.
go back to reference Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101:791–800.CrossRefPubMed Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101:791–800.CrossRefPubMed
6.
go back to reference Pharephan S, Sirivatanapa P, Makonkawkeyoon S, Tuntiwechapikul W, Makonkawkeyoon L. Prevalence of α-thalassaemia genotypes in pregnant women in northern Thailand. Indian J Med Res. 2016;143:315–22.CrossRefPubMedPubMedCentral Pharephan S, Sirivatanapa P, Makonkawkeyoon S, Tuntiwechapikul W, Makonkawkeyoon L. Prevalence of α-thalassaemia genotypes in pregnant women in northern Thailand. Indian J Med Res. 2016;143:315–22.CrossRefPubMedPubMedCentral
7.
go back to reference Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007;28:206.CrossRefPubMed Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007;28:206.CrossRefPubMed
8.
go back to reference Lin M, Zhu JJ, Wang Q, Xie LX, Lu M, Wang JL, et al. Development and evaluation of a reverse dot blot assay for the simultaneous detection of common alpha and beta thalassemia in Chinese. Blood Cells Mol Dis. 2012;48:86–90.CrossRefPubMed Lin M, Zhu JJ, Wang Q, Xie LX, Lu M, Wang JL, et al. Development and evaluation of a reverse dot blot assay for the simultaneous detection of common alpha and beta thalassemia in Chinese. Blood Cells Mol Dis. 2012;48:86–90.CrossRefPubMed
9.
go back to reference Chan V, Yam I, Chen FE, Chan TK. A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br J Haematol. 1999;104:513–5.CrossRefPubMed Chan V, Yam I, Chen FE, Chan TK. A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br J Haematol. 1999;104:513–5.CrossRefPubMed
10.
go back to reference Ye BC1, Zhang Z, Lei Z. Oligonucleotide array for detection of common severe determinants of alpha thalassemia. J Biotechnol. 2005;115:1–9.CrossRefPubMed Ye BC1, Zhang Z, Lei Z. Oligonucleotide array for detection of common severe determinants of alpha thalassemia. J Biotechnol. 2005;115:1–9.CrossRefPubMed
11.
go back to reference Zesong L, Ruijun G, Wen Z. Rapid detection of deletional alpha-thalassemia by an oligonucleotide microarray. Am J Hematol. 2005;80:306–8.CrossRefPubMed Zesong L, Ruijun G, Wen Z. Rapid detection of deletional alpha-thalassemia by an oligonucleotide microarray. Am J Hematol. 2005;80:306–8.CrossRefPubMed
12.
go back to reference Baysal E, Huisman THJ. Detection of common deletional α-thalassaemia-2 determinants by PCR. Am J Hematol. 1994;46:208–13.CrossRefPubMed Baysal E, Huisman THJ. Detection of common deletional α-thalassaemia-2 determinants by PCR. Am J Hematol. 1994;46:208–13.CrossRefPubMed
13.
go back to reference Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95:360–2.PubMed Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95:360–2.PubMed
14.
go back to reference Liu YT, Old JM, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of α-thalassaemia deletions andα-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108:295–9.CrossRefPubMed Liu YT, Old JM, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of α-thalassaemia deletions andα-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108:295–9.CrossRefPubMed
15.
go back to reference Chen TP, Liu TC, Chang CS, Chang JG, Tsai HJ, Lin SF. PCR-based analysis of alpha-thalassemia in Southern Taiwan. Int J Hematol. 2002;75:277–80.CrossRefPubMed Chen TP, Liu TC, Chang CS, Chang JG, Tsai HJ, Lin SF. PCR-based analysis of alpha-thalassemia in Southern Taiwan. Int J Hematol. 2002;75:277–80.CrossRefPubMed
16.
go back to reference Foglietta E, Bianco I, Maggio A, Giambona A. Rapid detection of six common Mediterranean and three non-Mediterranean α-thalassemia point mutations by reverse dot blot. Am J Hematol. 2003;74:191–5.CrossRefPubMed Foglietta E, Bianco I, Maggio A, Giambona A. Rapid detection of six common Mediterranean and three non-Mediterranean α-thalassemia point mutations by reverse dot blot. Am J Hematol. 2003;74:191–5.CrossRefPubMed
17.
go back to reference Puehringer H, Najmabadi H, Law HY, Krugluger W, Viprakasit V, Pissard S, et al. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common alpha-thalassemia point mutations and deletions. Clin Chem Lab Med. 2007;45:605–10.CrossRefPubMed Puehringer H, Najmabadi H, Law HY, Krugluger W, Viprakasit V, Pissard S, et al. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common alpha-thalassemia point mutations and deletions. Clin Chem Lab Med. 2007;45:605–10.CrossRefPubMed
18.
go back to reference Winichagoon P, Fucharoen S, Wasi P. The molecular basis of alpha-thalassemia in Thailand. Southeast Asian J Trop Med Public Health. 1992;23(Suppl 2):7–13.PubMed Winichagoon P, Fucharoen S, Wasi P. The molecular basis of alpha-thalassemia in Thailand. Southeast Asian J Trop Med Public Health. 1992;23(Suppl 2):7–13.PubMed
19.
go back to reference Lithanatudom P, Khampan P, Duncan RS, Svasti S, Fucharoen S, Kangwanpong D, et al. The prevalence of alpha-thalassemia amongst Tai and Mon-Khmer ethnic groups residing in northern Thailand: a population-based study. Hematology. 2016;21:480–5.CrossRefPubMed Lithanatudom P, Khampan P, Duncan RS, Svasti S, Fucharoen S, Kangwanpong D, et al. The prevalence of alpha-thalassemia amongst Tai and Mon-Khmer ethnic groups residing in northern Thailand: a population-based study. Hematology. 2016;21:480–5.CrossRefPubMed
20.
go back to reference Laosombat V, Viprakasit V, Chotsampancharoen T, Wongchanchailert M, Khodchawan S, Chinchang W, et al. Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88:1185–92.CrossRefPubMed Laosombat V, Viprakasit V, Chotsampancharoen T, Wongchanchailert M, Khodchawan S, Chinchang W, et al. Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88:1185–92.CrossRefPubMed
21.
go back to reference Pornprasert S, Punyamung M. Detection of compound heterozygous of Hb constant spring and Hb Q-Thailand by capillary electrophoresis and high performance liquid chromatography. Indian J Hematol Blood Transfus. 2015;31:229–32.CrossRefPubMed Pornprasert S, Punyamung M. Detection of compound heterozygous of Hb constant spring and Hb Q-Thailand by capillary electrophoresis and high performance liquid chromatography. Indian J Hematol Blood Transfus. 2015;31:229–32.CrossRefPubMed
22.
go back to reference Charoenkwan P, Taweephon R, Sae-Tung R, Thanarattanakorn P, Sanguansermsri T. Molecular and clinical features of Hb H disease in northern Thailand. Hemoglobin. 2005;29:133–40.CrossRefPubMed Charoenkwan P, Taweephon R, Sae-Tung R, Thanarattanakorn P, Sanguansermsri T. Molecular and clinical features of Hb H disease in northern Thailand. Hemoglobin. 2005;29:133–40.CrossRefPubMed
23.
go back to reference Yang Y, Lou JW, Liu YH, He Y, Li DZ. Screening and diagnosis of Hb Quong Sze [HBA2: c.377T> C (or HBA1)] in a prenatal control program for thalassemia. Hemoglobin. 2014;38:158–60.CrossRefPubMed Yang Y, Lou JW, Liu YH, He Y, Li DZ. Screening and diagnosis of Hb Quong Sze [HBA2: c.377T> C (or HBA1)] in a prenatal control program for thalassemia. Hemoglobin. 2014;38:158–60.CrossRefPubMed
24.
go back to reference Sanguansermsri T, Matragoon S, Changloah L, Flatz G. Hemoglobin Suan-Dok (α2 109(G16)LEU-ARGβ2). an unstable variant associated with α-thalassemia. Hemoglobin. 1979;3:161.CrossRefPubMed Sanguansermsri T, Matragoon S, Changloah L, Flatz G. Hemoglobin Suan-Dok (α2 109(G16)LEU-ARGβ2). an unstable variant associated with α-thalassemia. Hemoglobin. 1979;3:161.CrossRefPubMed
25.
go back to reference Bang-Ce Y, Hongqiong L, Zhuanfong Z, et al. Simultaneous detection of alpha-thalassemia and beta-thalassemia by oligonucleotide microarray. Haematologica. 2004;89:1010–2.PubMed Bang-Ce Y, Hongqiong L, Zhuanfong Z, et al. Simultaneous detection of alpha-thalassemia and beta-thalassemia by oligonucleotide microarray. Haematologica. 2004;89:1010–2.PubMed
26.
go back to reference Old J, Henderson S. Molecular diagnostics for haemoglobinopathies. Expert Opin Med Diagn. 2010;4:225–40.CrossRefPubMed Old J, Henderson S. Molecular diagnostics for haemoglobinopathies. Expert Opin Med Diagn. 2010;4:225–40.CrossRefPubMed
27.
go back to reference Harteveld CL, Kleanthous M, Traeger-Synodinos J. Prenatal diagnosis of hemoglobin disorders: present and future strategies. Clin Biochem. 2009;42:1767–79.CrossRefPubMed Harteveld CL, Kleanthous M, Traeger-Synodinos J. Prenatal diagnosis of hemoglobin disorders: present and future strategies. Clin Biochem. 2009;42:1767–79.CrossRefPubMed
Metadata
Title
Molecular characterization of Hb H disease in southern Thailand
Authors
Kesara Nittayaboon
Chamnong Nopparatana
Publication date
01-10-2018
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2018
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-2494-3

Other articles of this Issue 4/2018

International Journal of Hematology 4/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine